
Rita J Desai
Examiner (ID: 6660, Phone: (571)272-0684 , Office: P/1625 )
| Most Active Art Unit | 1625 |
| Art Unit(s) | 1612, 1625 |
| Total Applications | 2152 |
| Issued Applications | 1294 |
| Pending Applications | 146 |
| Abandoned Applications | 716 |
Applications
| Application number | Title of the application | Filing Date | Status |
|---|---|---|---|
Array
(
[id] => 15962977
[patent_doc_number] => 20200165240
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2020-05-28
[patent_title] => BENZOQUINOLONE INHIBITORS OF VMAT2
[patent_app_type] => utility
[patent_app_number] => 16/454174
[patent_app_country] => US
[patent_app_date] => 2019-06-27
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 13471
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => 0
[patent_words_short_claim] => 39
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16454174
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/454174 | BENZOQUINOLONE INHIBITORS OF VMAT2 | Jun 26, 2019 | Abandoned |
Array
(
[id] => 17266365
[patent_doc_number] => 11191769
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2021-12-07
[patent_title] => Fused thiophene compounds
[patent_app_type] => utility
[patent_app_number] => 16/438244
[patent_app_country] => US
[patent_app_date] => 2019-06-11
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 24417
[patent_no_of_claims] => 39
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 10
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16438244
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/438244 | Fused thiophene compounds | Jun 10, 2019 | Issued |
Array
(
[id] => 16665048
[patent_doc_number] => 10934279
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2021-03-02
[patent_title] => GLP-1 receptor agonists and uses thereof
[patent_app_type] => utility
[patent_app_number] => 16/436311
[patent_app_country] => US
[patent_app_date] => 2019-06-10
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 2
[patent_figures_cnt] => 2
[patent_no_of_words] => 49097
[patent_no_of_claims] => 16
[patent_no_of_ind_claims] => 3
[patent_words_short_claim] => 40
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16436311
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/436311 | GLP-1 receptor agonists and uses thereof | Jun 9, 2019 | Issued |
Array
(
[id] => 15254031
[patent_doc_number] => 20190375749
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2019-12-12
[patent_title] => KRAS G12C INHIBITORS AND METHODS OF USING THE SAME
[patent_app_type] => utility
[patent_app_number] => 16/436647
[patent_app_country] => US
[patent_app_date] => 2019-06-10
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 30724
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -43
[patent_words_short_claim] => 39
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16436647
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/436647 | KRAS G12C INHIBITORS AND METHODS OF USING THE SAME | Jun 9, 2019 | Abandoned |
Array
(
[id] => 15209681
[patent_doc_number] => 20190367527
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2019-12-05
[patent_title] => SUBSTITUTED PHENETHYLAMINE DERIVATIVES
[patent_app_type] => utility
[patent_app_number] => 16/428343
[patent_app_country] => US
[patent_app_date] => 2019-05-31
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 12521
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -11
[patent_words_short_claim] => 166
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16428343
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/428343 | Substituted phenethylamine derivatives | May 30, 2019 | Issued |
Array
(
[id] => 14836087
[patent_doc_number] => 20190276444
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2019-09-12
[patent_title] => BENZISOXAZOLES
[patent_app_type] => utility
[patent_app_number] => 16/423252
[patent_app_country] => US
[patent_app_date] => 2019-05-28
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 1681
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -9
[patent_words_short_claim] => 35
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16423252
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/423252 | BENZISOXAZOLES | May 27, 2019 | Abandoned |
Array
(
[id] => 15784837
[patent_doc_number] => 10626125
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2020-04-21
[patent_title] => 1,1,1-trifluoro-3-hydroxypropan-2-yl carbamate derivatives as MAGL inhibitors
[patent_app_type] => utility
[patent_app_number] => 16/420544
[patent_app_country] => US
[patent_app_date] => 2019-05-23
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 51679
[patent_no_of_claims] => 23
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 381
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16420544
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/420544 | 1,1,1-trifluoro-3-hydroxypropan-2-yl carbamate derivatives as MAGL inhibitors | May 22, 2019 | Issued |
Array
(
[id] => 14777891
[patent_doc_number] => 20190263843
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2019-08-29
[patent_title] => SUBSTITUTED PIPERIDINE COMPOUND AND USE THEREOF
[patent_app_type] => utility
[patent_app_number] => 16/410463
[patent_app_country] => US
[patent_app_date] => 2019-05-13
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 32861
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -16
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16410463
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/410463 | Substituted piperidine compound and use thereof | May 12, 2019 | Issued |
Array
(
[id] => 15178011
[patent_doc_number] => 20190359597
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2019-11-28
[patent_title] => PYRROLIDINYL UREA, PYRROLIDINYL THIOUREA AND PYRROLIDINYL GUANIDINE COMPOUNDS AS TRKA KINASE INHIBITORS
[patent_app_type] => utility
[patent_app_number] => 16/402080
[patent_app_country] => US
[patent_app_date] => 2019-05-02
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 75953
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -13
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16402080
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/402080 | PYRROLIDINYL UREA, PYRROLIDINYL THIOUREA AND PYRROLIDINYL GUANIDINE COMPOUNDS AS TRKA KINASE INHIBITORS | May 1, 2019 | Abandoned |
Array
(
[id] => 16399016
[patent_doc_number] => 20200339874
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2020-10-29
[patent_title] => BLUE EMITTER MATERIALS PRODUCED THROUGH NOVEL REDUCTIVE ELIMINATION PROCESS
[patent_app_type] => utility
[patent_app_number] => 16/395348
[patent_app_country] => US
[patent_app_date] => 2019-04-26
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 3027
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -11
[patent_words_short_claim] => 10
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16395348
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/395348 | BLUE EMITTER MATERIALS PRODUCED THROUGH NOVEL REDUCTIVE ELIMINATION PROCESS | Apr 25, 2019 | Abandoned |
Array
(
[id] => 14712621
[patent_doc_number] => 20190247374
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2019-08-15
[patent_title] => CHROMANE, ISOCHROMANE AND DIHYDROISOBENZOFURAN DERIVATIVES AS mGluR2-NEGATIVE ALLOSTERIC MODULATORS, COMPOSITIONS, AND THEIR USE
[patent_app_type] => utility
[patent_app_number] => 16/392131
[patent_app_country] => US
[patent_app_date] => 2019-04-23
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 29007
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -12
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16392131
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/392131 | Chromane, isochromane and dihydroisobenzofuran derivatives as mGluR2-negative allosteric modulators, compositions, and their use | Apr 22, 2019 | Issued |
Array
(
[id] => 14929777
[patent_doc_number] => 20190300526
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2019-10-03
[patent_title] => PRODRUGS OF FUSED-BICYCLIC C5aR ANTAGONISTS
[patent_app_type] => utility
[patent_app_number] => 16/371627
[patent_app_country] => US
[patent_app_date] => 2019-04-01
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 38105
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -38
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16371627
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/371627 | PRODRUGS OF FUSED-BICYCLIC C5aR ANTAGONISTS | Mar 31, 2019 | Abandoned |
Array
(
[id] => 14566731
[patent_doc_number] => 20190210972
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2019-07-11
[patent_title] => METHODS OF RESOLVING RACEMIC MIXTURE TO OBTAIN (-)-HUPERZINE A
[patent_app_type] => utility
[patent_app_number] => 16/358460
[patent_app_country] => US
[patent_app_date] => 2019-03-19
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 5383
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -17
[patent_words_short_claim] => 114
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16358460
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/358460 | Methods of resolving racemic mixture to obtain (-)-Huperzine A | Mar 18, 2019 | Issued |
Array
(
[id] => 16353064
[patent_doc_number] => 10793565
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2020-10-06
[patent_title] => Heterocyclic compounds as immunomodulators
[patent_app_type] => utility
[patent_app_number] => 16/296563
[patent_app_country] => US
[patent_app_date] => 2019-03-08
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 25777
[patent_no_of_claims] => 16
[patent_no_of_ind_claims] => 4
[patent_words_short_claim] => 12
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16296563
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/296563 | Heterocyclic compounds as immunomodulators | Mar 7, 2019 | Issued |
Array
(
[id] => 15163207
[patent_doc_number] => 10487083
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2019-11-26
[patent_title] => Small molecule inhibitors of the JAK family of kinases
[patent_app_type] => utility
[patent_app_number] => 16/275045
[patent_app_country] => US
[patent_app_date] => 2019-02-13
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 6
[patent_figures_cnt] => 6
[patent_no_of_words] => 26246
[patent_no_of_claims] => 12
[patent_no_of_ind_claims] => 7
[patent_words_short_claim] => 6
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16275045
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/275045 | Small molecule inhibitors of the JAK family of kinases | Feb 12, 2019 | Issued |
Array
(
[id] => 16955982
[patent_doc_number] => 11059823
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2021-07-13
[patent_title] => Small molecule inhibitors of the JAK family of kinases
[patent_app_type] => utility
[patent_app_number] => 16/274142
[patent_app_country] => US
[patent_app_date] => 2019-02-12
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 6
[patent_figures_cnt] => 6
[patent_no_of_words] => 26184
[patent_no_of_claims] => 37
[patent_no_of_ind_claims] => 4
[patent_words_short_claim] => 14
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16274142
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/274142 | Small molecule inhibitors of the JAK family of kinases | Feb 11, 2019 | Issued |
Array
(
[id] => 14684819
[patent_doc_number] => 20190241524
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2019-08-08
[patent_title] => COMPOUNDS FOR THE TREATMENT OF PAIN
[patent_app_type] => utility
[patent_app_number] => 16/267025
[patent_app_country] => US
[patent_app_date] => 2019-02-04
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 87826
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -22
[patent_words_short_claim] => 84
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16267025
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/267025 | Compounds for the treatment of pain | Feb 3, 2019 | Issued |
Array
(
[id] => 15634311
[patent_doc_number] => 10590132
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2020-03-17
[patent_title] => Selective estrogen receptor down-regulators
[patent_app_type] => utility
[patent_app_number] => 16/263683
[patent_app_country] => US
[patent_app_date] => 2019-01-31
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 64928
[patent_no_of_claims] => 12
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 98
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16263683
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/263683 | Selective estrogen receptor down-regulators | Jan 30, 2019 | Issued |
Array
(
[id] => 15663877
[patent_doc_number] => 10596145
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2020-03-24
[patent_title] => Heterocyclic flavone derivatives, compositions, and methods related thereto
[patent_app_type] => utility
[patent_app_number] => 16/259754
[patent_app_country] => US
[patent_app_date] => 2019-01-28
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 26
[patent_figures_cnt] => 36
[patent_no_of_words] => 16789
[patent_no_of_claims] => 14
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 7
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16259754
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/259754 | Heterocyclic flavone derivatives, compositions, and methods related thereto | Jan 27, 2019 | Issued |
Array
(
[id] => 16506102
[patent_doc_number] => 20200385358
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2020-12-10
[patent_title] => METHOD FOR PRODUCING CALCOBUTROL
[patent_app_type] => utility
[patent_app_number] => 16/962287
[patent_app_country] => US
[patent_app_date] => 2019-01-11
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 1623
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -4
[patent_words_short_claim] => 49
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16962287
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/962287 | Method for producing calcobutrol | Jan 10, 2019 | Issued |